(SIADH) is a condition characterized by an abnormal release of antidiuretic hormone (ADH), also known as vasopressin, from the pituitary gland or other sources in the body. ADH is responsible for regulating water balance in the body by increasing water reabsorption in the kidneys, which leads to concentrated urine and reduced urine output. However, in SIADH, there is an excessive release of ADH, causing the body to retain too much water and leading to a decrease in serum sodium levels (hyponatremia).
Some common causes of SIADH include certain medications, lung diseases, brain injuries, tumors (especially lung cancers), and central nervous system disorders. Symptoms of SIADH may vary depending on the severity of hyponatremia and can include nausea, vomiting, headache, confusion, muscle cramps, weakness, and in severe cases, seizures and coma.
Diagnosis of SIADH involves assessing the patient's medical history, conducting blood and urine tests to evaluate sodium levels, ADH levels, and kidney function, and performing imaging studies to identify potential underlying causes such as tumors or brain injuries. Treatment aims to address the underlying cause, correct hyponatremia, and manage symptoms. Depending on the severity, treatment may include fluid restriction, discontinuation of medications causing SIADH, administration of medications to inhibit ADH release (such as demeclocycline or tolvaptan), and in some cases, interventions like surgery or radiation to remove or manage the underlying cause.
Overall, SIADH is a complex condition that requires proper diagnosis, treatment, and management to restore water and electrolyte balance in the body and prevent potential complications related to hyponatremia. It is important for individuals experiencing symptoms of SIADH to consult a healthcare professional for proper evaluation and management.